Michel Chofflon

2.5k total citations
62 papers, 1.5k citations indexed

About

Michel Chofflon is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Michel Chofflon has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 17 papers in Neurology and 17 papers in Immunology. Recurrent topics in Michel Chofflon's work include Multiple Sclerosis Research Studies (25 papers), Peripheral Neuropathies and Disorders (10 papers) and Immunotherapy and Immune Responses (10 papers). Michel Chofflon is often cited by papers focused on Multiple Sclerosis Research Studies (25 papers), Peripheral Neuropathies and Disorders (10 papers) and Immunotherapy and Immune Responses (10 papers). Michel Chofflon collaborates with scholars based in Switzerland, United States and France. Michel Chofflon's co-authors include Patrice H. Lalive, David A. Hafler, Mahdia Benkhoucha, Howard L. Weiner, Catherine Juillard, Chikao Morimoto, J. Delavelle, Georges E. Grau, Marie‐Laure Santiago‐Raber and Danielle Burger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michel Chofflon

61 papers receiving 1.4k citations

Peers

Michel Chofflon
Michel Chofflon
Citations per year, relative to Michel Chofflon Michel Chofflon (= 1×) peers Charlotte Dahle

Countries citing papers authored by Michel Chofflon

Since Specialization
Citations

This map shows the geographic impact of Michel Chofflon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Chofflon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Chofflon more than expected).

Fields of papers citing papers by Michel Chofflon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Chofflon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Chofflon. The network helps show where Michel Chofflon may publish in the future.

Co-authorship network of co-authors of Michel Chofflon

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Chofflon. A scholar is included among the top collaborators of Michel Chofflon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Chofflon. Michel Chofflon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allali, Gilles, Magali Laidet, Frédéric Assal, et al.. (2014). Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients. European Neurology. 71(5-6). 247–251. 14 indexed citations
2.
Allali, Gilles, Magali Laidet, Frédéric Assal, et al.. (2012). Adapted Timed Up and Go: A Rapid Clinical Test to Assess Gait and Cognition in Multiple Sclerosis. European Neurology. 67(2). 116–120. 39 indexed citations
3.
Haller, Sven, Vítor Mendes Pereira, Patrice H. Lalive, et al.. (2009). Magnetic Resonance Imaging in Multiple Sclerosis. Topics in Magnetic Resonance Imaging. 20(6). 313–323. 3 indexed citations
4.
Lalive, Patrice H., S Kantengwa, Mahdia Benkhoucha, Catherine Juillard, & Michel Chofflon. (2008). Interferon-β induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients. Journal of Neuroimmunology. 197(2). 147–151. 34 indexed citations
5.
Kantengwa, S, Michael A. Weber, Catherine Juillard, et al.. (2007). Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis. Journal of Neuroimmunology. 185(1-2). 123–129. 17 indexed citations
6.
Lalive, Patrice H., et al.. (2007). Neuromyélite optique/syndrome de Devic: avancées et perspectives. Revue Médicale Suisse. 3(106). 950–955.
7.
Mégevand, Pierre, Carlo Chizzolini, Michel Chofflon, et al.. (2007). Cerebrospinal Fluid Anti-SSA Autoantibodies in Primary Sjögren’s Syndrome with Central Nervous System Involvement. European Neurology. 57(3). 166–171. 16 indexed citations
8.
Chofflon, Michel. (2005). Mechanisms of Action for Treatments in??Multiple Sclerosis. BioDrugs. 19(5). 299–308. 27 indexed citations
9.
Lalive, Patrice H., Pierre R. Burkhard, & Michel Chofflon. (2002). TNF-α and psychologically stressful events in healthy subjects: Potential relevance for multiple sclerosis relapse.. Behavioral Neuroscience. 116(6). 1093–1097. 13 indexed citations
10.
Pieh, Christina, et al.. (2002). Isolated Unilateral Adduction Deficit and Ptosis as the Presenting Features of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Journal of Neuro-Ophthalmology. 22(2). 92–94. 11 indexed citations
11.
Chofflon, Michel, et al.. (2002). Long-term benefits of early and high doses of interferon β-1a treatment in relapsing–remitting multiple sclerosis. Clinical Neurology and Neurosurgery. 104(3). 244–248. 9 indexed citations
12.
Fellay, Benoı̂t, et al.. (2001). Beneficial effect of co‐polymer 1 on cytokine production by CD4 T cells in multiple sclerosis. Immunology. 104(4). 383–391. 3 indexed citations
13.
Chofflon, Michel. (2000). Recombinant human interferon beta in relapsing–remitting multiple sclerosis: a review of the major clinical trials. European Journal of Neurology. 7(4). 369–380. 24 indexed citations
14.
Chofflon, Michel, et al.. (1999). Cerebrospinal fluid in acute peripheral facial palsy. Journal of Neurology. 246(3). 165–169. 24 indexed citations
15.
Diserens, Karin, et al.. (1998). Corticosteroid-Responsive Postmalaria Encephalopathy Characterized by Motor Aphasia, Myoclonus, and Postural Tremor. Archives of Neurology. 55(3). 417–417. 41 indexed citations
16.
Ebers, George C., D. W. Paty, Mark S. Freedman, et al.. (1997). The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis. Oxford University Research Archive (ORA) (University of Oxford). 2 indexed citations
17.
Lou, Jin-Ning, Michel Chofflon, Catherine Juillard, et al.. (1997). Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity. Neuroreport. 8(3). 629–633. 39 indexed citations
18.
Chofflon, Michel, Víctor Baladrón González, Howard L. Weiner, & David A. Hafler. (1989). Inflammatory cerebrospinal fluid t cells have activation requirements characteristic of cd4+cd45ra t cells. European Journal of Immunology. 19(10). 1791–1795. 13 indexed citations
19.
Chofflon, Michel, Howard L. Weiner, Chikao Morimoto, & David A. Hafler. (1989). Decrease of suppressor inducer (cd4+ 2h4+) t cells in multiple sclerosis cerebrospinal fluid. Annals of Neurology. 25(5). 494–499. 50 indexed citations
20.
Chofflon, Michel, Howard L. Weiner, Chikao Morimoto, & David A. Hafler. (1988). Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4 + 2H4 +) T Cells in multiple sclerosis. Annals of Neurology. 24(2). 185–191. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026